Amneal Pharmaceuticals LLC.

In News

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA® - GlobeNewswire

GlobeNewswire - Dec 22, 2025

Amneal gets FDA warning letter tied to prior recalls of antibacterial products - Fierce Pharma

Fierce Pharma - Sep 04, 2025

Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan - Investing.com

Investing.com - Jul 24, 2025

Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results - Yahoo Finance

Yahoo Finance - Jul 21, 2025

Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension - GlobeNewswire

GlobeNewswire - Sep 04, 2025

Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01% - Yahoo Finance

Yahoo Finance - Sep 23, 2025

Amneal Launches Brekiya® – the First and Only DHE - GlobeNewswire

GlobeNewswire - Oct 27, 2025

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol - Yahoo Finance

Yahoo Finance - Oct 29, 2025

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals - GlobeNewswire

GlobeNewswire - Dec 09, 2025

Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab) - Yahoo Finance

Yahoo Finance - Sep 26, 2025

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults - GlobeNewswire

GlobeNewswire - May 15, 2025

Amneal to Report Third Quarter 2025 Results on October 30, 2025 - GlobeNewswire

GlobeNewswire - Sep 30, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment